Lina Life Insurance Allows Enrollment in Targeted Cancer Treatment Riders for Patients with Pre-existing Conditions and Elderly

[Asia Economy Reporter Oh Hyung-gil] LINA Life Insurance announced on the 9th that it will expand the targeted cancer treatment focused coverage benefits for policyholders with pre-existing conditions and elderly individuals.

The underwriting criteria for the Targeted Anticancer Drug Approval Treatment Rider have been simplified, allowing policyholders with pre-existing conditions or advanced age to add targeted cancer treatment as a rider. Previously, it was difficult to enroll if diagnosed with any of the top 10 diseases such as hypertension or diabetes within the past 5 years.

LINA One-Question Cancer Insurance allows enrollment as long as there has been no diagnosis, hospitalization, or surgery for cancer, carcinoma in situ, or cirrhosis within the past 5 years. The eligible age for enrollment has also been expanded from 60 to 80 years old. The company explained that policyholders with pre-existing conditions or advanced age often need to prioritize anticancer treatment over surgery, so preparation for the latest medical technologies such as targeted cancer treatment is necessary.

Jo Ji-eun, Vice President of LINA Life Insurance, said, "Expanding the targeted anticancer focused coverage rider in the simplified disclosure cancer insurance is expected to further solidify the perception that when it comes to cancer insurance, it is LINA Life Insurance."

This content was produced with the assistance of AI translation services.